CClinicalTrials.gg
Status unknownNCT04017676Updated Jul 12, 2019

Optimizing the Resources of Psychotherapy as a Tool for Implementing the Mental Health Reform

An interventional study of Supervision assissted by measures in Psychotherapy Research and Outcome Measures, sponsored by Shalvata Mental Health Center. Status unknown. Per ClinicalTrials.gov, last updated 2019-07-12.

Sponsored by Shalvata Mental Health Center · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jul 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Sex
All
01

Study summary

Psychotherapy is one of the cornerstones in public and private mental health services. Despite the tremendous investment in psychotherapy, its efficiency ranges from 40% to 60%. Given the Mental health Reform (2015), aimed at increasing the quality, availability, and accessibility of mental health services, there is an urgent need to manage and maximize psychotherapy services in Israel.

Read the detailed description

Objectives: To examine the feasibility of implementing managing (monitor and interventional) procedures in psychotherapy services conducted in public mental health services, to assess their effect on the outcome, and to estimate their impact on the 2015 Mental Health Reform objectives.

Working hypotheses:

  • After appropriate preparation, managed psychotherapeutic service will be implemented in 4 public mental health out-patients clinics;
  • Managed psychotherapeutic service will lead to an improvement in the outcome of psychotherapy;
  • Managed psychotherapeutic service will increase the efficacy of mental health services.

Methods:

Type of study: A multicenter, randomized, controlled study with a group comparison and a program trial, in which the subjects are recruited according to a systematic allocation by order.

Since in the field of psychotherapy, "measure means affect," there is a built-in difficulty in building control groups (which are also committed to evaluation). For this reason, the proposed study combines a control group comparison.

Research population: The study will be carried out in the therapeutic settings of two psychiatric hospitals: the Shalvata Mental Health Center and the Geha Mental Health Center. The study population will include patients receiving therapeutic services in the ambulatory system of these centers (three clinics, the Shalvata Mental Health Center, one clinic, the Geha Mental Health Center). The study population includes patients with all the common mental disorders (adjustment disorders, anxiety, depression, personality disorders and somatomorphic disorders). The allocation between caregivers will be random in order, in a one-to-one ratio.

Research groups: The proposed study has two groups. Both groups include patients who are actively receiving psychotherapy on a weekly basis for at least three months to neutralize the effects of starting treatment. The first group will be under the usual treatment conditions (TAU); The second group will be exposed to a multidisciplinary therapeutic program that has a monitoring component and after two months an intervening component will be. In order to reduce the effect of the treated variables and the analysis of nested data, each therapist will introduce two patients into the study: one patient will be in the normal treatment condition (TAU) and the other under the monitoring and intervention program. In order to ensure randomization in this allocation, the clinic manager will determine the identity of the patients (i.e., each therapist will recruit two patients, and the allocation decision will be made anonymously by the clinic manager).

Inclusion criteria: Included are patients over the age of 18 years who have agreed to participate in the study, were found suitable for psychotherapeutic treatment and are treated with the attending clinician for at least two months. Patients who (due to cognitive impairment, language gaps, etc.) are not able to complete questionnaires with little help will not be included in the study. In order to minimize the effect of external variables, patients who, in the opinion of the clinician, are expected to undergo significant pharmacological changes (change in non-sleeping drugs or occasional sedatives) will not be inclusesd Population of caregivers: Experienced therapists from various therapeutic professions (including psychologists, social workers, psychiatrists, and other therapists who are graduates of psychotherapy training programs) will participate in the study. Only therapist who have a proven experience of at least 6 months in the clinic and manage at least four treatments at the beginning of the study will participate.

Data collection: Data collection will be carried out through computerized information systems (computerized medical records, by an application on a cellular device currently being developed as part of the project).

Research tools and variables: The primary outcome measure of the study is the OQ-45 (Lambert, M. J., Gregersen, A.T., Burlingame, G.M. (2004). The Outcome Questionnaire-45 The use of psychological testing for treatment planning and outcomes assessment: Volume 3: Instruments for adults (3rd ed) (pp. 191-234). Mahwah, NJ, US: Lawrence Erlbaum Associates Publishers).

Methods of data analysis: Differences between groups will be examined using chi-squared tests (in categorical variables) or by independent T-tests and Mann-Whitney tests (non-categorical variables). Time differences will be analyzed by ANCOVA (repeated measures) and TSA (time series analysis). The sample size estimation is 68 patients.

Importance: Managed psychotherapeutic service has the potential to improve the clinical outcomes, and to increase the efficiency of the mental health services following the goals of the 2015 Mental Health Reform.

02

Conditions studied

  • Psychotherapy Research and Outcome Measures
03

In context

Lead sponsor

Shalvata Mental Health Center is the lead sponsor of 73 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Included are patients over the age of 18 years who have agreed to participate in the study, were found suitable for psychotherapeutic treatment and are treated with the attending clinician for at least two months.

Exclusion criteria

Exclusion Criteria:

Patients who (due to cognitive impairment, language gaps, etc.) are not able to complete questionnaires with little help will not be included in the study. In order to minimize the effect of external variables, patients who, in the opinion of the clinician, are expected to undergo significant pharmacological changes (change in non-sleeping drugs or occasional sedatives) will not be included

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • No intervention
    Control group

    The first group will be under the usual treatment conditions (TAU)

  • Experimental
    Experimental group

    The second group will be exposed to a multidisciplinary therapeutic program that has a monitoring component and after two months an intervening component will be.

    Other: Supervision assissted by measures

Interventions

  • OtherSupervision assissted by measures

    In the weeks 10 and 13, about 72 hours after the meeting scheduled for that week, and before the next therapeutic session, there will be a structured training session (based on the recommendations of Krägeloh et al., 2015), based on information in the literature about the various questionnaires

06

What researchers measure

Primary outcomes

  1. Change in OQ45

    The primary outcome measure of the study is the OQ-45 (Lambert, M. J., Gregersen, A.T., Burlingame, G.M. (2004). The Outcome Questionnaire-45 The use of psychological testing for treatment planning and outcomes assessment: Volume 3: Instruments for adults (3rd ed) (pp. 191-234). Mahwah, NJ, US: Lawrence Erlbaum Associates Publishers).

    Time frame: Initiation, Week 4, Week 7, Week 20

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 12, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04017676
Lead sponsor
Shalvata Mental Health Center
Collaborators
Geha Mental Health Center
Responsible party
Sponsor
First posted
Jul 12, 2019
Start date
Oct 2020 (estimated)
Primary completion
Jan 2021 (estimated)
Completion
Apr 2021 (estimated)
Last update
Jul 12, 2019

Study contacts

Shlomo Mendlovic, MD
Contact
mendlovic@clalit.org.il
972-50-6770178

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion